Hi
@Easytiger,
We’ve been over this before, many times. They can’t attach a $$$$ amount to it yet. Plus it hasn’t finished the trials yet to even get into mass production phase.
At the moment it is just a potential customer trying to build a product. When the product becomes real and a contract is signed with a tangible order/amount then I would suggest it could/should be announced if it’s not a trade secret (which I would think it could be).
If Brainchip makes an announcement at this stage and the product fails testing, for whatever reason then how will that look to shareholders/investors. It could also be seen as ramping, e.g. promoting a fake medical device such as Theranos; do we really want to go there? What would the SP be like then?
Plus, it’s not Brainchip‘s place to make an announcement anyway if it’s a trade secret. Hence Antonio’s line at the AGM last year. “The share price will do as the share price does.” The SP will be determined by customers and revenue, not fluff announcements.
I am hopeful there are many many companies in the pipeline such as Know Labs. It is also what makes this investment so exciting that at some time in the future the products/sales/royalties will begin. Which is why our CEO stated “Watch the financials.” He is well aware that using Akida will be a competitive advantage in new products which never existed before therefore they will be trade secrets and not disclosed.
The fact there have been no leaks and the companies such as Intel and AI LABS comes out of the blue is a testament to Brainchip professionalism and would enhance their standing within their customer base and potential customers!
If I was running a company such as Know Labs, trying to be first to market with a new medical device I would not be telling anyone about it until It was proven successful in trials, approved by the TGA and I could announce it hitting the market during a product launch. That would ensure my first mover advantage and ensure I got a return on my investment. At that time I still might not want to let the public/competitor know how my device works, e.g. Akida inside; so they can’t replicate similar and compete for my revenue. I’m sure Know Labs wants to be as profitable as possible.
If it wasn’t hinted at during the Edge Impulse presentation we would be none the wiser at this time.
I want Know Labs to be very successful in which case we will be successful. Plus how good will it feel to be in a potentially live saving medical device which makes sick peoples lives easier!